1. Home
  2. UVV vs SPTX Comparison

UVV vs SPTX Comparison

Compare UVV & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$45.62

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$24.08

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UVV
SPTX
Founded
1886
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
UVV
SPTX
Price
$45.62
$24.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
302.5K
106.4K
Earning Date
05-28-2026
N/A
Dividend Yield
6.25%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,885,078,000.00
N/A
Revenue This Year
$0.67
N/A
Revenue Next Year
$0.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$43.36
$17.59
52 Week High
$59.38
$26.32

Technical Indicators

Market Signals
Indicator
UVV
SPTX
Relative Strength Index (RSI) 33.10 64.32
Support Level $43.36 $18.72
Resistance Level $54.26 N/A
Average True Range (ATR) 1.45 1.54
MACD -0.23 0.04
Stochastic Oscillator 20.38 57.03

Price Performance

Historical Comparison
UVV
SPTX

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Tobacco Operations segment involves procuring and processing flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products and performing related services. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, the Philippines, Germany, and Other Countries, with the majority of revenue from the USA.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: